- Home
- CENN vs AKTX Comparison
CENN vs AKTX Comparison
Compare CENN & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENN
- AKTX
- Stock Information
- Founded
- CENN 2013
- AKTX N/A
- Country
- CENN United States
- AKTX United States
- Employees
- CENN N/A
- AKTX N/A
- Industry
- CENN Auto Manufacturing
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- CENN Consumer Discretionary
- AKTX Health Care
- Exchange
- CENN Nasdaq
- AKTX Nasdaq
- Market Cap
- CENN 32.4M
- AKTX 32.8M
- IPO Year
- CENN N/A
- AKTX N/A
- Fundamental
- Price
- CENN $1.01
- AKTX $1.12
- Analyst Decision
- CENN
- AKTX
- Analyst Count
- CENN 0
- AKTX 0
- Target Price
- CENN N/A
- AKTX N/A
- AVG Volume (30 Days)
- CENN 116.7K
- AKTX 25.4K
- Earning Date
- CENN 02-18-2025
- AKTX 02-15-2025
- Dividend Yield
- CENN N/A
- AKTX N/A
- EPS Growth
- CENN N/A
- AKTX N/A
- EPS
- CENN N/A
- AKTX N/A
- Revenue
- CENN $37,052,841.00
- AKTX N/A
- Revenue This Year
- CENN N/A
- AKTX N/A
- Revenue Next Year
- CENN N/A
- AKTX N/A
- P/E Ratio
- CENN N/A
- AKTX N/A
- Revenue Growth
- CENN 142.48
- AKTX N/A
- 52 Week Low
- CENN $0.97
- AKTX $0.90
- 52 Week High
- CENN $2.30
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- CENN 30.70
- AKTX 46.66
- Support Level
- CENN $0.97
- AKTX $1.10
- Resistance Level
- CENN $1.07
- AKTX $1.35
- Average True Range (ATR)
- CENN 0.06
- AKTX 0.13
- MACD
- CENN -0.01
- AKTX -0.00
- Stochastic Oscillator
- CENN 16.67
- AKTX 30.77
About CENN Cenntro Electric Group Limited
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles. Its vehicles include Metro, Logistar 400, Logistar 200, Neibor 200, and ORV. The company's geographical segments include Europe, America, and Asia.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).